【ChiCTR2500104207】Randomized Controlled Trail: Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
ChiCTR2500104207
结束
/
/
/
2025-06-12
/
/
NA
Randomized Controlled Trail: Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
1. conduct a comprehensive patient assessment using drone when emergency, 2. validate if the TAM framework can also contribute to understanding public decision making with respect to the adoption of drones in medical response.
随机平行对照
其它
In this parallel group RCT, participants were randomly allocated into two groups: (1) non-injury control or (2) simulated acute ankle sprain in 1:1 ratio using a computer-generated sequence (block randomisation, block size = 4) stratified by prior drone experience (<10 vs. >=10 hours).
Single bind to research
/
/
64
/
2023-08-01
2024-11-30
/
Experience in emergency response；
请登录查看participants younger than 14 years old, which do not meet the Hong Kong Drone Law requirement；
请登录查看Caritas Institute of Higher Education
/
Caritas Institute of Higher Education的其他临床试验
- Randomized Controlled Trail: Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
- Clinical Training Dosage of Robotic Exoskeleton Assisted Gait Training for Improvement of Gait Parameters, Walking Performance, Balance and Health-related Benefits in Patients with Chronic Stroke: a Randomized Control Trial
Hong Kong Metropolitan University的其他临床试验
- Effectiveness of an immersive virtual reality (VR)-based mindfulness intervention (MI) to reduce depressive symptoms in patients with autoimmune arthritis (AA): a randomized control trial (RCT)
- Randomized Controlled Trail: Medical Assessment and Response by Small-unmanned-aerial-system (MARS)
- Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial
- Acute and chronic musculoskeletal pain situations among adults and their educational requirements on pain in mainland China: an exploratory study
最新临床资讯
-
护肾先锋 | 逆转“不可逆”：88岁高龄“糖尿病肾病”患者，精准诊治重获新生
广东省中医院2026-08-14
-
破除临床痛点，医院原创冠脉微循环无创诊疗技术获全球权威认可
西南医院2026-08-14
-
bioSeedin柏思荟2026-08-14
-
迈同生物2026-08-14
-
COD医材汇2026-08-14
-
九源基因2026-08-14
-
丁香园 Insight 数据库2026-08-14
-
辐联科技Full Life Technologies2026-08-14
-
茵诺医药2026-08-14
-
优赛生命2026-08-14
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-14
-
2026-08-14
-
2026-08-14
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
同适应症药物临床试验
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-14
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 37
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29